Our Commitment to Belgium and Luxembourg
Gilead pursued and achieved advancement in sciences in the areas of unmet medical need – setting out to make the impossible possible.
For more than 35 years, Gilead has pursued the impossible, working to bring forward medicines for life-threatening diseases and tackle viruses such as HIV, hepatitis B (HBV), hepatitis C (HCV) and COVID-19, and continue our focus on cancer and inflammatory diseases. Our ambition is clear. Together, with our partners, Gilead wants to continue the path to cure and give patients access. Our future is creating possible.
Our commitment is to look beyond our medicines: to listen, learn and find effective solutions in the areas that matter most. Our goal is to create a healthier world for all people. We believe in collaboration and partnership with our healthcare system and patient groups and are especially proud of our efforts in this area. Gilead further supports programs that provide education, prevention and care for some of the most vulnerable communities.
We began our journey in Belgium in 2008 with a focus of ensuring access to our innovative treatments for Belgium and Luxembourg.
Our Team in Belgium
Our highly skilled teams are committed to improving care for people across Belgium and Luxembourg.
Should you be interested in joining our team, please consult the career options.
